ArticleScientific reports2025
Incidence and predictors of type 2 diabetes mellitus during 17 years of follow-up in the Golestan Cohort Study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The influence of regular monitoring and exercise on employee health: A study at Cicendo Eye Hospital measuring differences between clinical and non-clinical staff.Public health in practice (Oxford, England) · 2026Article
- Waist circumference and grip strength and their joint relations to type 2 diabetes incidence in UK Biobank.BMC medicine · 2026Article
- Association of baseline osteocalcin and femoral neck bone mineral density in healthy women with future risk of fractures, cardiovascular disease, diabetes and death.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we aimed to determine the incidence and predictors of type 2 Diabetes Mellitus (T2DM) in the Golestan Cohort Study (GCS). This study is a prospective population-based cohort study conducted in the Golestan province of Iran with the participation of 50,044 people aged 30 to 87 years between 2004 and 2008. Participants were followed up for 17 years for T2DM. The cumulative incidence of T2DM was 13.32% in the GCS. We observed hypertension (HTN) and dyslipidemia (DLP) increased the risk of T2DM 1.16 and 1.63 times relative to the healthy participants (RR: 1.16, 1.63, 95% CI : 1.102-1.222, 1.393-1.928, p < 0.001). For every one-unit increase in the body mass index (BMI), the risk of T2DM increased 1.09 times (RR: 1.09, 95% CI :1.086-1.106, p < 0.001). High-risk waist circumference (WC) increased the risk of T2DM by 1.89 times more than normal WC (RR: 1.89, 95% CI : 1.756-2.053, p < 0.001). Smokers had an 89% lower risk of T2DM than non-smokers (RR: 0.897, 95% CI : 0.814-0.989, p = 0.029). We conclude that environmental factors induce T2DM by affecting body fat. Also, other metabolic diseases could develop T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.